The legacy of Viagra, and its developer copyright, presents a complex case study for investors. Initially a blockbuster drug, yielding billions in revenue , its exclusivity period created a deluge of generic https://cruxbookmarks.com/story21483117/copyright-s-pill-and-big-pharma-a-risky-investment